KNSA - Kiniksa Pharmaceuticals Ltd - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

KNSA is currently covered by 4 analysts with an average price target of $28.71. This is a potential upside of $10.85 (60.75%) from yesterday's end of day stock price of $17.86.

Kiniksa Pharmaceuticals Ltd's activity chart (see below) currently has 41 price targets and 34 ratings on display. The stock rating distribution of KNSA is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 21.93% with an average time for these price targets to be met of 148.8 days.

Highest price target for KNSA is $32, Lowest price target is $24, average price target is $28.71.

Most recent stock forecast was given by LIISA BAYKO from EVERCORE on 24-Apr-2024. First documented stock forecast 18-Jun-2018.

Best performing analysts who are covering KNSA - Kiniksa Pharmaceuticals Ltd:

Geoff Meacham Anupam Rama Liisa Bayko Paul Choi David Nierengarten

Currently out of the existing stock ratings of KNSA, 9 are a BUY (100%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

30

$12.14 (67.97%)

18

1 days ago

1/7 (14.29%)

$12.14 (67.97%)

134

Buy

24

$6.14 (34.38%)

23

3 months 6 days ago

2/7 (28.57%)

$5.12 (27.12%)

116

Buy

25

$7.14 (39.98%)

23

3 months 23 days ago

1/7 (14.29%)

$6.47 (34.92%)

147

Buy

32

$14.14 (79.17%)

24

9 months ago

1/8 (12.5%)

$12.52 (64.27%)

68

Buy

28

$10.14 (56.77%)

34

2 years 2 months 2 days ago

2/5 (40%)

$18.01 (180.28%)

279

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is KNSA (Kiniksa Pharmaceuticals Ltd) average time for price targets to be met?

On average it took 148.8 days on average for the stock forecasts to be realized with a an average price target met ratio 21.93

Which analyst has the current highest performing score on KNSA (Kiniksa Pharmaceuticals Ltd) with a proven track record?

GEOFF MEACHAM

Which analyst has the current lower performing score on KNSA (Kiniksa Pharmaceuticals Ltd) with a proven track record?

DAVID NIERENGARTEN

Which analyst has the most public recommendations on KNSA (Kiniksa Pharmaceuticals Ltd)?

Geoff Meacham works at BAML and has 9 price targets and 7 ratings on KNSA

Which analyst is the currently most bullish on KNSA (Kiniksa Pharmaceuticals Ltd)?

Paul Choi with highest potential upside - $14.14

Which analyst is the currently most reserved on KNSA (Kiniksa Pharmaceuticals Ltd)?

Anupam Rama with lowest potential downside - $6.14

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?